海默内提克斯

最新新闻

• 评级变动
  Barrington Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $118
  \u5e02\u573a\u8d44\u8baf · 2026/8/19
• 评级变动
  Mizuho Securities Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $95
  \u5e02\u573a\u8d44\u8baf · 2026/8/12
• 公司公告
  Hae In: Report on significant holdings of stocks, etc. (General)
  OPENDART · 2026/8/24
• 公司公告
  Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Miller Laurie A.
  SEC · 2025/9/25
• Baird Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $119
  \u5e02\u573a\u8d44\u8baf · 2026/8/21
• Raymond James Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $125
  \u5e02\u573a\u8d44\u8baf · 2026/9/3
• 评级变动
  A Quick Look at Today's Ratings for Haemonetics(HAE.US), With a Forecast Between $92 to $96
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• Barrington Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $118
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• Citi Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $123
  \u5e02\u573a\u8d44\u8baf · 2026/9/18
• 公司公告
  Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Miller Laurie A.
  SEC · 2025/6/10
• 评级变动
  A Quick Look at Today's Ratings for Haemonetics(HAE.US), With a Forecast Between $92 to $105
  \u5e02\u573a\u8d44\u8baf · 2026/8/8
• 公司公告
  4: Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Miller Laurie A.
  SEC · 2026/6/9
• 评级变动
  J.P. Morgan Sticks to Its Hold Rating for Haemonetics (HAE)
  TipRanks · 2026/8/11
• 评级变动
  Needham Maintains Haemonetics(HAE.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/18
• Citi Upgrades Haemonetics(HAE.US) to Buy Rating, Raises Target Price to $123
  \u5e02\u573a\u8d44\u8baf · 2026/9/17
• 评级变动
  BofA Securities Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $100
  \u5e02\u573a\u8d44\u8baf · 2026/8/12
• 公司公告
  Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Miller Laurie A.
  SEC · 2026/5/20
• 评级变动
  BofA Securities Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $120
  \u5e02\u573a\u8d44\u8baf · 2026/8/18
• 评级变动
  BofA Securities Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $120
  \u5e02\u573a\u8d44\u8baf · 2026/8/18
• 评级变动
  Citi Maintains Haemonetics(HAE.US) With Hold Rating, Maintains Target Price $92
  \u5e02\u573a\u8d44\u8baf · 2026/8/13

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。